TXG
10X Genomics Inc
79.10$
+3.3%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 90.1% | 85.5% | 79.4% | 83.3% | 73.4% | 61.7% | 61.8% | 63.6% | 65.7% | |
| 63.3% | 52.4% | 70.0% | 71.4% | 57.7% | 21.4% | 37.2% | 37.5% | 45.5% | |
| 63.3% | 52.4% | 70.0% | 71.4% | 57.7% | 41.8% | 40.3% | 42.8% | 50.3% | |
| 17.6% | 22.6% | 5.5% | 5.5% | 8.4% | 10.1% | 11.9% | 9.6% | 7.9% | |
| 6.4% | 6.9% | 2.5% | 3.2% | 5.9% | 7.9% | 7.6% | 9.0% | 5.4% | |
| 9.2% | 9.0% | 8.1% | 7.8% | 22.6% | 28.1% | – | – | – | |
| 0.0% | 0.0% | – | 0.0% | 0.4% | 0.4% | 0.5% | 0.5% | 0.4% | |
| 0.0% | 0.3% | 0.1% | 2.4% | 2.5% | 2.2% | 1.7% | 1.7% | 6.0% | |
| 248.8% | 277.0% | 30.7% | 20.5% | 19.8% | 21.7% | 23.2% | 22.7% | 23.5% | |
| 29.3% | 26.0% | 10.4% | 12.7% | 10.8% | 12.7% | 13.2% | 12.8% | 14.7% | |
| 5.6% | 3.4% | 1.6% | 0.6% | 0.5% | 0.9% | 1.2% | 1.0% | 1.1% | |
| 7.2% | 7.1% | 2.2% | 0.5% | 1.7% | 2.1% | 1.6% | 1.4% | 1.2% | |
| 8.4% | 20.5% | 3.3% | – | – | – | – | – | – | |
| -148.8% | -177.0% | 69.3% | 79.5% | 80.2% | 78.3% | 76.8% | 77.3% | 76.5% | |
| -156.9% | -185.9% | -43.3% | -86.6% | -84.7% | -100.0% | -133.1% | -159.7% | -145.1% | |
| 15.3% | 10.8% | 12.9% | 10.9% | 10.8% | 11.1% | 12.1% | 13.1% | 12.0% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.